K. Fücker

Therapeutic Potentials of Acarbose as First-Line Drug in NIDDM Insufficiently Treated With Diet Alone

M Hanefeld, Sabine Fischer, Jan Schulze et al. · Diabetes Care · 1991 · 180 citations

Nutrition, Pharmacotherapy, Metabolic Syndrome +19

Insulin-resistant patients with type 2 diabetes mellitus have higher serum leptin levels independently of body fat mass

Sabine Fischer, M Hanefeld, Steven M. Haffner et al. · Acta Diabetologica · 2002 · 160 citations

Insulin Resistance, Metabolic Syndrome, Obesity +12

Anomalies of lipoprotein pattern and fibrinolysis in acromegalic patients: Relation to growth hormone levels and insulin-like growth factor I

J. Wildbrett, M Hanefeld, K. Fücker et al. · Experimental and Clinical Endocrinology & Diabetes · 2009 · 47 citations

Acromegalic Patients, Hyperlipidemia, Igf-i Levels +18

Glibenclamide, but Not Acarbose, Increases Leptin Concentrations Parallel to Changes in Insulin in Subjects With NIDDM

Steven M. Haffner, M Hanefeld, Sabine Fischer et al. · Diabetes Care · 1997 · 40 citations

Obesity, Metabolic Syndrome, Leptin Concentration +13

Relation of free and specifically bound leptin to insulin secretion in patients with impaired glucose tolerance (IGT)

W. Leonhardt, R. Horn, G. Brabant et al. · Experimental and Clinical Endocrinology & Diabetes · 2009 · 16 citations

Nutrition, Metabolic Disorder, Immunology +18